Endometrial ablation for refractory postmenopausal bleeding with continuous hormone replacement therapy

1994 ◽  
Vol 62 (6) ◽  
pp. 1181-1185 ◽  
Author(s):  
Lyman B. Spaulding
Keyword(s):  
Hormone Replacement Therapy ◽  
Replacement Therapy ◽  
Hormone Replacement ◽  
Endometrial Ablation ◽  
Postmenopausal Bleeding

Hysteroscopy in women with abnormal uterine bleeding on hormone replacement therapy: a comparison with postmenopausal bleeding

1996 ◽  
Vol 65 (6) ◽  
pp. 1145-1150 ◽  
Author(s):  
Fritz Nagele ◽  
Hugh O’Connor ◽  
Thomas F. Baskett ◽  
Anthony Davies ◽  
Hossam Mohammed ◽  
...  
Keyword(s):  
Hormone Replacement Therapy ◽  
Replacement Therapy ◽  
Hormone Replacement ◽  
Abnormal Uterine Bleeding ◽  
Uterine Bleeding ◽  
Postmenopausal Bleeding

Postmenopausal bleeding

2013 ◽  
Vol 6 (11) ◽  
pp. 709-716
Author(s):  
Rebecca Pugh ◽  
Anna Humphries
Keyword(s):  
Endometrial Cancer ◽  
Hormone Replacement Therapy ◽  
Replacement Therapy ◽  
Secondary Care ◽  
Hormone Replacement ◽  
Postmenopausal Bleeding ◽  
Urgent Referral ◽  
Underlying Malignancy ◽  
Unscheduled Bleeding ◽  
Careful History

Postmenopausal bleeding (PMB) is one of the most common reasons for referral to gynaecology services. This is due to the concern of possible underlying malignancy, as approximately 10% of women with PMB will have endometrial cancer. With growing use of hormone replacement therapy there is increased uncertainty as to what constitutes unscheduled bleeding and careful history and examination is required. Although benign conditions represent the most frequent cause of PMB, all women will require urgent referral and investigation in secondary care.

scholarly journals Hormone replacement therapy in women with postovariectomy syndrome and endometrial ablation

2005 ◽  
Vol 54 (4) ◽  
pp. 31-34
Author(s):  
М. I. Yarmolinskaya ◽  
М. A. Tarasova
Keyword(s):  
Hormone Replacement Therapy ◽  
Replacement Therapy ◽  
Operative Treatment ◽  
Endometrial Hyperplasia ◽  
Conservative Therapy ◽  
Hormone Replacement ◽  
Endometrial Ablation ◽  
Clinical Presentations ◽  
Highly Effective

The aim of the study was to estimate the efficacy and tolerance of hormone replacement therapy using Femoston 1/5 in women with postovariectomy syndrome who had undergone endometrial ablation. We examined 37 patients aged 47-52 years suffering from moderate and severe postovariectomy syndrome. All of them underwent endometrial ablation and bilateral adnexectomy due to recurrent endometrial hyperplasia and lack of effect from conservative therapy. During 1,5-2,5 years after operative treatment they received combined oestrogen-gestagen replacement therapy using Femoston 1/5. This preparation was shown to be highly effective for reduction of clinical presentations of postovariectomy syndrome. No influence on endometrial state was found.

Sign in / Sign up

Export Citation Format

Share Document